Company
United StatesPublic company, NYSE: XTNTXTANT Medical Holdings, Inc (NYSE: XTNT), Belgrade, MT – FDA Inspections
Inspection records and compliance data for XTANT Medical Holdings, Inc in Belgrade, Montana. 14 FDA inspections on record (2 OAI), last inspected August 13, 2021. Publicly traded as NYSE: XTNT.
Company Profile
This profile covers XTANT Medical Holdings, Inc based in Belgrade, Montana, United States.
FDA Inspection History
- FDA inspections
- 14
- OAI
- 2
- VAI
- 4
- NAI
- 8
- Form 483s
- 0
- Warning letters
- 0
First inspected April 23, 2009. Last inspected August 13, 2021.
Most cited issue areas
- Lack of or inadequate complaint procedures2 inspections
- Lack of or inadequate procedures2 inspections
- Not approved or obsolete document retrieval2 inspections
FDA inspections (14)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 13, 2021 | NAI | Biologics · Vaccines and Allergenic Products | 1149034 |
| August 25, 2017 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1026635 |
| August 21, 2017 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1024416 |
| May 18, 2016 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 969771 |
| May 1, 2014 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 876734 |
| August 2, 2013 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 843894 |
| July 12, 2013 | VAI | Medical Devices & Rad Health · Compliance: Devices | 840320 |
| July 11, 2013 | NAI | Medical Devices & Rad Health · Compliance: Devices | 840318 |
| July 27, 2012 | OAI | Medical Devices & Rad Health · Compliance: Devices | 793050 |
| July 26, 2012 | OAI | Biologics, Medical Devices & Rad Health · Compliance: Devices | 793041 |
| August 10, 2011 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 745194 |
| April 27, 2011 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 721935 |
| May 7, 2009 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 581564 |
| April 23, 2009 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 580248 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
XTANT Medical Holdings, Inc
Stock ticker
XTNT
Exchange
NYSE
Share price
$0.30
Market cap
$42.2M
Price as of
November 6, 2026
FEI Number
3005031160
Address
664 Cruiser Ln, Belgrade, Montana 59714, United States
Country
United States
ID: e2642f74-9c48-4235-8aa9-5073f449fbc7